MyFinsight
Home
About
Contact
mygn: the income statement
Download
Download image
Revenue From Contract
With Customer...
$38,700K
Revenue From Contract
With Customer...
$44,500K
Non Us
$2,800K
US
$26,700K
Non Us
$11,200K
US
$81,800K
Net loss
-$27,400K
(-23.98%↓ Y/Y)
Pharmacogenomics
$38,700K
(-18.87%↓ Y/Y)
Prenatal Testing
$44,500K
Tumor Profiling
$29,500K
Hereditary Cancer Testing
$93,000K
Income tax expense
(benefit)
$1,200K
(33.33%↑ Y/Y)
Loss before income
tax
-$26,200K
(-23.58%↓ Y/Y)
Revenue
$205,700K
(-3.56%↓ Y/Y)
Total other income
(expense), net
-$2,900K
(-141.67%↓ Y/Y)
Operating loss
-$23,300K
(-16.50%↓ Y/Y)
Other
$400K
(150.00%↑ Y/Y)
Interest income
$500K
(25.00%↑ Y/Y)
Gross profit
$143,800K
Cost of revenue
$61,900K
(-2.52%↓ Y/Y)
Interest expense
$3,800K
(375.00%↑ Y/Y)
Total operating
expenses
$167,100K
General and
administrative expense
$67,900K
Sales and marketing
expense
$71,000K
Research and development
expense
$28,200K
(-1.05%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)